The production of recombinant pharmaceutical proteins in plants

JKC Ma, PMW Drake, P Christou - Nature reviews genetics, 2003 - nature.com
Imagine a world in which any protein, either naturally occurring or designed by man, could
be produced safely, inexpensively and in almost unlimited quantities using only simple …

Medical molecular farming: production of antibodies, biopharmaceuticals and edible vaccines in plants

H Daniell, SJ Streatfield, K Wycoff - Trends in plant science, 2001 - cell.com
The use of plants for medicinal purposes dates back thousands of years but genetic
engineering of plants to produce desired biopharmaceuticals is much more recent. As the …

[BOOK][B] Introduction to plant biotechnology (3/e)

HS Chawla - 2011 - taylorfrancis.com
This book has been written to meet the needs of students for biotechnology courses at
various levels of undergraduate and graduate studies. This book covers all the important …

Vaccination against coronaviruses in domestic animals

IR Tizard - Vaccine, 2020 - Elsevier
The current pandemic of COVID-19 has set off an urgent search for an effective vaccine. This
search may well benefit from the experiences of the animal health profession in the …

Edible vaccines: Promises and challenges

VM Kurup, J Thomas - Molecular biotechnology, 2020 - Springer
Vaccines are biological preparations that improve immunity to particular diseases and form
an important innovation of 19th century research. It contains a protein that resembles a …

Approaches to achieve high‐level heterologous protein production in plants

SJ Streatfield - Plant biotechnology journal, 2007 - Wiley Online Library
Plants offer an alternative to microbial fermentation and animal cell cultures for the
production of recombinant proteins. For protein pharmaceuticals, plant systems are …

Rice-based mucosal vaccine as a global strategy for cold-chain-and needle-free vaccination

T Nochi, H Takagi, Y Yuki, L Yang… - Proceedings of the …, 2007 - National Acad Sciences
Capable of inducing antigen-specific immune responses in both systemic and mucosal
compartments without the use of syringe and needle, mucosal vaccination is considered …

Plant-based vaccines and antibodies to combat COVID-19: current status and prospects

K Dhama, S Natesan, M Iqbal Yatoo… - Human Vaccines & …, 2020 - Taylor & Francis
Globally, researchers are undertaking significant efforts to design and develop effective
vaccines, therapeutics, and antiviral drugs to curb the spread of coronavirus disease 2019 …

Clinical development of plant-produced recombinant pharmaceuticals: vaccines, antibodies and beyond

V Yusibov, SJ Streatfield, N Kushnir - Human vaccines, 2011 - Taylor & Francis
In the last few years, plants have become an increasingly attractive platform for recombinant
protein production. This builds on two decades of research, starting with transgenic …

Plants as bioreactors: recent developments and emerging opportunities

AK Sharma, MK Sharma - Biotechnology advances, 2009 - Elsevier
In recent years, the use of plants as bioreactors has emerged as an exciting area of research
and significant advances have created new opportunities. The driving forces behind the …